CD274 and rectal cancer: At this stage, studies regarding the expression of PD-L1 in rectal cancer and its variations following neoadjuvant therapy are limited overall, and their results are largely inconsistent [34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51].